What is Vasoplegic Shock?
Vasoplegic shock is a type of circulatory failure in which the blood vessels lose their normal tone, becoming extremely dilated (vasodilation) and unable to maintain adequate blood pressure. Even though the heart may be pumping normally, the systemic vascular resistance (SVR) drops dramatically, leading to insufficient organ perfusion and, if untreated, organ failure.
It is most commonly encountered in the setting of major surgery (especially cardiac surgery), severe infection, or after exposure to certain drugs. Because the problem is primarily vascular rather than cardiac, conventional treatments for cardiogenic shock (such as inotropes) often have limited benefit; instead, therapies that restore vascular tone are essential.
Common Causes
The following conditions are most frequently associated with vasoplegic shock. In many cases multiple factors interact, creating a “perfect storm” of vasodilation.
- Cardiopulmonary bypass (CPB) and cardiac surgery – exposure of blood to artificial surfaces triggers inflammatory mediators.
- Severe sepsis or septic shock – endotoxin and cytokine release cause profound vasodilation.
- Major trauma – massive tissue injury releases inflammatory mediators and activates the nitric‑oxide pathway.
- Hypothermia and re‑warming – temperature extremes alter vascular smooth‑muscle responsiveness.
- High‑dose vasodilator medications – nitroprusside, nitroglycerin, or certain anesthetics.
- Endocrine emergencies – adrenal insufficiency (e.g., Waterhouse‑Friderichsen syndrome) or severe hypothyroidism.
- Massive blood product transfusion – especially plasma-rich products that contain complement‑activating proteins.
- Allergic anaphylaxis – histamine and other mediators cause sudden systemic vasodilation.
- Genetic or acquired nitric‑oxide synthase overactivity – seen in some rare metabolic disorders.
- Drug overdose – opioids, calcium channel blockers, and certain psychotropic agents.
Associated Symptoms
Because vasoplegic shock is a circulatory emergency, patients often present with a constellation of systemic signs reflecting under‑perfusion of vital organs.
- Profoundly low blood pressure (systolic < 80 mmHg or MAP < 65 mmHg)
- Warm, flushed skin (due to vasodilation) rather than the cool, clammy skin seen in hypovolemic shock
- Rapid, weak pulse (tachycardia compensating for low pressure)
- Altered mental status – confusion, agitation, or loss of consciousness
- Decreased urine output (< 0.5 mL/kg/h) indicating renal hypoperfusion
- Elevated lactate levels (metabolic acidosis) as cells switch to anaerobic metabolism
- Chest discomfort or mild dyspnea if the heart cannot keep up with the demands
- Signs of the underlying trigger (e.g., fever and rigors in sepsis, surgical wound drainage after cardiac surgery)
When to See a Doctor
Vasoplegic shock is a medical emergency. If you or someone else exhibits any of the following, seek immediate medical attention (call emergency services in your country, e.g., 911 in the U.S.).
- Sudden drop in blood pressure with dizziness or fainting
- Rapid, weak pulse and rapid breathing
- Confusion, disorientation, or loss of consciousness
- Markedly decreased urine output or no urination for several hours
- Warm, flushed skin that feels unusually dry or “hot” despite low blood pressure
- History of recent major surgery, severe infection, or exposure to potent vasodilators followed by the above symptoms
Diagnosis
Diagnosing vasoplegic shock involves a systematic evaluation to confirm the type of shock, identify the underlying cause, and assess the severity of organ dysfunction.
Initial Clinical Assessment
- Vital signs: blood pressure, heart rate, respiratory rate, oxygen saturation, temperature.
- Physical exam focusing on skin temperature, capillary refill, mental status, and signs of fluid loss or infection.
Laboratory Tests
- Complete blood count (CBC) – detect infection or anemia.
- Basic metabolic panel – renal function, electrolytes.
- Lactate level – a key marker of tissue hypoperfusion (values > 2 mmol/L are concerning).
- Arterial blood gas (ABG) – assess acid‑base status.
- C-reactive protein (CRP) and procalcitonin – help gauge inflammatory/septic processes.
- Serum cortisol and adrenal labs if adrenal insufficiency is suspected.
- Drug levels/toxicology screen if overdose is possible.
Hemodynamic Monitoring
- Invasive arterial line for real‑time blood pressure and blood‑gas analysis.
- Central venous pressure (CVP) or pulmonary artery catheter to differentiate between low‑volume and vasodilatory states.
- Echocardiography – evaluates cardiac function, ruling out primary cardiac failure.
Imaging and Special Tests
- Chest X‑ray or CT to look for pneumonia, pulmonary edema, or other thoracic pathology.
- Abdominal imaging if intra‑abdominal infection or bleeding is suspected.
- Blood cultures (at least two sets) before starting antibiotics when infection is a possible trigger.
Guidelines from the Surviving Sepsis Campaign and the American College of Cardiology recommend this systematic approach to quickly identify vasoplegic shock and start targeted therapy (Mayo Clinic, 2023; ACC, 2022).
Treatment Options
Treatment is aimed at three pillars: (1) restoring adequate vascular tone and blood pressure, (2) treating the underlying cause, and (3) supporting organ function.
Immediate Stabilization (Emergency Department / Operating Room)
- Fluid resuscitation – 30 mL/kg isotonic crystalloid bolus (e.g., normal saline or lactated Ringer’s) is given *only* if hypovolemia is present. Excessive fluids can worsen pulmonary edema, especially after cardiac surgery.
- Vasopressors – First‑line agents include norepinephrine (to increase SVR) and phenylephrine (pure alpha‑agonist). Doses are titrated to maintain MAP ≥ 65 mmHg.
- Vasopressin – 0.03–0.04 U/min can be added when high doses of catecholamines are needed; it works via V1 receptors and reduces catecholamine requirement.
- Methylene‑blue – In refractory vasoplegia (often after CPB), low‑dose methylene‑blue (1–2 mg/kg IV) inhibits nitric‑oxide synthase and has demonstrated benefit in several randomized trials (Cleveland Clinic, 2021).
Targeted Therapy for Underlying Causes
- Sepsis – Broad‑spectrum antibiotics within the first hour, source control (drainage of abscesses, removal of infected lines), and anticoagulation if indicated.
- Cardiac surgery‑related – Review perfusion techniques, consider re‑warming, and administer steroids (e.g., hydrocortisone 50 mg IV q6h) if adrenal suppression is suspected.
- Allergic/anaphylactic shock – Intramuscular epinephrine 0.3–0.5 mg, antihistamines, and corticosteroids.
- Drug overdose – Specific antidotes (e.g., naloxone for opioids, calcium gluconate for calcium‑channel blocker toxicity) and supportive care.
Organ‑Support Measures
- Mechanical ventilation – For respiratory failure or severe acidosis.
- Renal replacement therapy (RRT) – When oliguria or rising creatinine indicates acute kidney injury.
- Inotropic support – If cardiac output remains low despite adequate MAP, agents such as dobutamine may be added.
Long‑Term and Home‑Based Care
Once the acute crisis resolves, patients may need follow‑up for the underlying condition (e.g., infection control, endocrine evaluation). Home care focuses on medication adherence, wound care after surgery, and early detection of recurrent symptoms.
- Continue oral vasopressor taper (e.g., low‑dose midodrine) only under specialist supervision.
- Antibiotic courses as prescribed, with completion to prevent relapse.
- Endocrine replacement (e.g., hydrocortisone) if adrenal insufficiency is diagnosed.
- Regular monitoring of blood pressure, weight, and urine output.
Prevention Tips
While some triggers (e.g., emergency trauma) cannot be prevented, many strategies reduce the risk of vasoplegic shock, especially in high‑risk settings.
- Optimize peri‑operative management – Use minimally invasive techniques when possible, maintain normothermia, and limit CPB time.
- Prophylactic steroids – In high‑risk cardiac surgery, low‑dose hydrocortisone has been shown to lower vasoplegia incidence (JAMA Cardiology, 2022).
- Judicious use of vasodilators – Titrate nitroprusside, nitroglycerin, or anesthetic agents carefully and monitor SVR.
- Early infection control – Prompt treatment of cellulitis, urinary tract infections, or pneumonia reduces progression to sepsis.
- Vaccinations – Influenza, pneumococcal, and COVID‑19 vaccines lower the risk of severe infection that could precipitate shock.
- Medication reconciliation – Review all drugs, especially over‑the‑counter vasodilators, before surgery or hospital admission.
- Stress‑dose steroids – Patients with known adrenal insufficiency should carry a medical alert and a hydrocortisone emergency kit.
- Monitoring during high‑risk procedures – Continuous arterial pressure monitoring and early vasopressor availability during major surgeries.
Emergency Warning Signs
- Sudden, severe drop in blood pressure (systolic < 80 mmHg) with dizziness or fainting.
- Rapid, weak pulse combined with rapid breathing.
- Warm, flushed skin that feels unusually hot despite low pressure.
- Confusion, agitation, or loss of consciousness.
- Very low urine output (less than 0.5 mL/kg/hr) or no urination for several hours.
- Elevated lactate (> 2 mmol/L) indicating tissue hypoxia.
- Recent major surgery, severe infection, or exposure to high‑dose vasodilator drugs.
If any of these signs appear, call emergency services immediately – vasoplegic shock can progress to multi‑organ failure within minutes.
**References** (selected)
- Mayo Clinic. “Septic shock.” Updated 2023. mayoclinic.org
- Surviving Sepsis Campaign. “International Guidelines for Management of Sepsis and Septic Shock.” 2023.
- American College of Cardiology. “Management of Vasoplegic Syndrome After Cardiac Surgery.” 2022.
- Cleveland Clinic. “Methyleneblue for Refractory Vasoplegia.” JACC, 2021.
- World Health Organization. “Guidelines on Prevention and Treatment of Sepsis.” 2022.